- There were around 43,400 new cases of prostate cancer in the UK in 2012, that’s around 119 men every day.
- Prostate cancer is the third most common cancer in the UK (2012).
- Prostate cancer accounts for 13% of all new cases in the UK (2012).
- In men, prostate cancer is the most common cancer in the UK, with around 43,400 cases diagnosed in 2012.
- More than a third (36%) of prostate cancer cases are diagnosed in men aged over 75 years.
- Since the late-1970s, prostate cancer incidence rates have more than doubled (147% increase) in Great Britain, although much of the increase is due to increased detection through widespread use of the PSA test.
- Over the last decade, prostate cancer incidence rates have increased by less than a tenth (5%) in the UK.
- In Europe, around 417,000 new cases of prostate cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 17th highest in Europe.
- Worldwide, more than 1.11 million men were estimated to have been diagnosed with prostate cancer in 2012, with incidence rates varying across the world.
Prostate cancer statistics
New cases of prostate cancer, 2012, UK
Deaths from prostate cancer, 2012, UK
Survive prostate cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of prostate cancer are not known as it is not clearly linked to any preventable risk factors
- Prostate cancer is the second most common cause of cancer death in UK men, after lung cancer.
- In 2012 in the UK around 10,800 men died from prostate cancer, that's 30 every day.
- Almost three quarters of prostate cancer deaths occur in men aged 75 and over.
- Prostate cancer death rates peaked in the early 1990s and have since fallen by around a fifth.
- In Europe, around 92,300 men were estimated to have died from prostate cancer in 2012. The UK mortality rate is 15th highest in Europe.
- Worldwide, more than 307,000 men were estimated to have died from prostate cancer in 2012, with mortality rates varying across the world.
- More than 8 in 10 (84%) men diagnosed with prostate cancer in England and Wales survive their disease for ten years or more (2010-11).
- Almost 9 in 10 (85%) men diagnosed with prostate cancer in England and Wales survive their disease for five years or more (2010-11).
- Almost 95% (94%) of men diagnosed with prostate cancer in England and Wales survive their disease for one year or more (2010-11).
- Prostate cancer survival is highest for men diagnosed aged 50-69 years old, probably because of PSA testing.
- More than 9 in 10 men diagnosed aged 50-69 survive their disease for five years or more, compared with around 6 in 10 men diagnosed aged 80 and over.
- Prostate cancer survival is improving and has tripled in the last 40 years in the UK, probably because of PSA testing.
- In the 1970s, a quarter of men diagnosed with prostate cancer survived their disease beyond ten years, now it's more than 8 in 10.
- When diagnosed at its earliest stage, all men with prostate cancer will survive their disease for five years or more, compared with less than a third of men when diagnosed at the latest stage.
- Prostate cancer is not clearly linked to any preventable risk factors.
- A man’s risk of developing prostate cancer depends on many factors, including age,genetics, and possibly exposure to risk factors.
- No modifiable factors have been conclusively linked with prostate cancer risk, though many factors have been studied. Use of PSA testing often makes interpretation of evidence difficult.
- Some factors may relate to higher prostate cancer risk, including certain occupational exposures, ionising radiation, and certain medical conditions, but evidence is unclear.
- Some foods and supplements may relate to lower prostate cancer risk, but evidence is unclear.
- GP referral (not ‘two-week wait’) is the most common route to diagnosis of prostate cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62-day wait’ are not met by any country for urological cancers.
The latest statistics available for prostate cancer in the UK are; incidence 2012, mortality 2012 and survival 2010-2011.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Stage at diagnosis data is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Prostate cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.